PCSA
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. (PCSA) has 22 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Business - Strategy Off Lin Patrick with 4 filings.
- Industry:Biotechnology
- CEO:George K. Ng
- Employees:10
- HQ:Hanover, MD, US
- IPO:2014-03-07
Insider Buying
$90K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$6.2M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Business - Strategy Off | Purchase | 2,106 | $4K | Jul 1 | SEC ↗ | |
| Chief Financial Officer | Purchase | 3,277 | $6K | Jul 1 | SEC ↗ | |
| Pres. Research & Development | Purchase | 2,531 | $5K | Jul 1 | SEC ↗ | |
| Chief Executive Officer | Purchase | 3,057 | $6K | Jul 1 | SEC ↗ | |
| Chief Administrative Officer | Purchase | 2,436 | $5K | Jul 1 | SEC ↗ | |
| Chief Business - Strategy Off | Purchase | 1,831 | $4K | Jun 16 | SEC ↗ | |
| Pres. Research & Development | Purchase | 2,067 | $5K | Jun 16 | SEC ↗ | |
| Chief Financial Officer | Purchase | 2,654 | $6K | Jun 16 | SEC ↗ | |
| Chief Executive Officer | Purchase | 2,465 | $5K | Jun 16 | SEC ↗ | |
| Chief Administrative Officer | Purchase | 2,118 | $5K | Jun 16 | SEC ↗ | |
Ng George KFirst filing | Chief Executive Officer | Purchase | 2,129 | $5K | Jun 1 | SEC ↗ |
| Chief Business - Strategy Off | Purchase | 1,582 | $4K | Jun 1 | SEC ↗ | |
Guy WendyFirst filing | Chief Administrative Officer | Purchase | 1,829 | $5K | Jun 1 | SEC ↗ |
| Chief Financial Officer | Purchase | 2,292 | $6K | Jun 1 | SEC ↗ | |
| Pres. Research & Development | Purchase | 1,786 | $5K | Jun 1 | SEC ↗ | |
Lin PatrickFirst filing | Chief Business - Strategy Off | Purchase | 1,369 | $4K | May 19 | SEC ↗ |
SKIBSTED RUSSELLFirst filing | Chief Financial Officer | Purchase | 1,984 | $6K | May 19 | SEC ↗ |
Young DavidFirst filing | Pres. Research & Development | Purchase | 1,545 | $5K | May 19 | SEC ↗ |
Related companies
Processa Pharmaceuticals, Inc. is in the Healthcare sector.